IMMUNITYBIO, INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ddf8382d-5348-40e2-9b96-16a8ca57338f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-351.5M | 2025-01-01 – 2025-12-31 | evidence 0001326110-26-000049 |
| FY 2024 | $-413.6M | 2024-01-01 – 2024-12-31 | evidence 0001326110-26-000049 |
| FY 2023 | $-583.9M | 2023-01-01 – 2023-12-31 | evidence 0001326110-26-000049 |
| FY 2022 | $-417.3M | 2022-01-01 – 2022-12-31 | evidence 0001326110-26-000049 |
| FY 2021 | $-349.8M | 2021-01-01 – 2021-12-31 | evidence 0001326110-26-000049 |
| FY 2020 | $-221.9M | 2020-01-01 – 2020-12-31 | evidence 0001326110-22-000011 |
| FY 2019 | $-157.8M | 2019-01-01 – 2019-12-31 | evidence 0001326110-22-000011 |
| FY 2018 | $-96.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007562 |
| FY 2017 | $-96.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005290 |
| FY 2016 | $-120.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004430 |
| FY 2015 | $-236.9M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-015596 |
| FY 2014 | $-6.2M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-015596 |
| FY 2013 | $-2.0M | 2013-01-01 – 2013-12-31 | evidence 0001564590-16-015596 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).